Cancer Immunotherapy: A Treatment for the Masses

By J. Blattman, P. Greenberg. Science, 2004

645 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Mixed immunotherapy and chemotherapy of tumors: modeling, applications and biological interpretations. (2006, positive): “…potential of immune system control of certain malignancies has motivated new research into the development of immunotherapies and vaccine therapies for cancers (see, for example Blattman and Greenberg, 2004; Couzin, 2002; Donnelly, 2003; Pardoll, 1998; Rosenberg et al., 2004; Wheeler et al., 2004).”
Physical approaches to biomaterial design (2009, background): “The availability of new materials has spurred the development of immunotherapies that use vaccines against diseases including certain cancer”
TGF-β directly targets cytotoxic T cell functions during tumor evasion of immune surveillance (2005, neutral): “The ultimate goal of cancer immunotherapy is to restore or enhance the ability of tumor antigen-specific T cells to recognize and eliminate tumor cells in vivo (Blattman and Greenberg, 2004).”